Prof. Xi Cheng 程玺
Chief Physician, Professor
Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Multidisciplinary treatment of cervical, ovarian, uterine body, vulvar cancers, and gynecologic malignancies. Expertise includes surgery, chemotherapy, radiotherapy, targeted therapy, and immunotherapy, with specialized procedures for fertility preservation and quality of life.
Dr. Cheng holds a PhD in gynecologic oncology from Fudan University and completed postdoctoral training at MD Anderson Cancer Center in 2007. With 20 years of clinical experience, Dr. Cheng focuses on multidisciplinary care for gynecologic tumors. Research includes clinical trials on bevacizumab, topotecan, and trabectedin. Dr. Cheng has published over 20 SCI papers and contributed to several medical textbooks.
Professional roles
- Vice Chair, Gynecologic Oncology Expert Committee, Beijing Medical Reward Foundation
- Member, Gynecologic Oncology Medical Education Committee, China Medicine Education Association
- Member, Gynecologic Oncology Professional Committee, Shanghai Physician Association
- Member, Gynecologic Oncology Professional Committee, Shanghai Anti-Cancer Association
Name order: in Chinese the family name comes first (Cheng Xi). Papers usually list the name as Xi Cheng or Cheng X.
Selected publications
56 papers on PubMed matched by name and affiliation; 19 as first or senior author since 2016. Most recent first- or senior-author papers:
- Open Med (Wars), 2025 (senior author): Risk and prognosis for brain metastasis in primary metastatic cervical cancer patients: A population-based study. PubMed 40918152
- Sci Rep, 2025 (senior author): Significant prognostic value of cell-cycle proteins in early-stage small cell carcinoma of cervix. PubMed 40702150
- J Gynecol Oncol, 2025 (senior author): Different surgical methods for FIGO stage IVB cervical cancer patients receiving chemotherapy: a population-based study. PubMed 39482929
- J Transl Med, 2024 (senior author): Functional genetic variants of GEN1 predict overall survival of Chinese epithelial ovarian cancer patients. PubMed 38890669
- Comb Chem High Throughput Screen, 2023 (senior author): A Novel Risk Model of SUMOylation-related Genes Associated with Prognosis in Endometrial Cancer. PubMed 35598238
- Cancer Commun (Lond), 2021 (senior author): Programmed death ligand-1 regulates angiogenesis and metastasis by participating in the c-JUN/VEGFR2 signaling axis in ovarian cancer. PubMed 33939321
- Curr Probl Cancer, 2021 (senior author): Integrated analysis of tumor mutation burden and immune infiltrates in endometrial cancer. PubMed 33012523
- Jpn J Clin Oncol, 2020 (senior author): Construction and validation of a prognostic nomogram for primary vulvar melanoma: a SEER population-based study. PubMed 32776099
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion